Enoxaparin sodium

SKU: orb1940414

Description

Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).

Images & Validation

−

Key Properties

−

CAS Number	679809-58-6
MW	1322
Purity	>98% (HPLC)
Formula	C₄₂H₅₉N₃Na₄O₃₅S₂
Target	Parasite\|N-myristoyltransferase-1 (NMT-1)

Storage & Handling

−

Storage	Storage temperature: -20°C. Stability: ≥ 2 years
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Parasite|N-myristoyltransferase-1 (NMT-1)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols